Haemonetics · 7 hours ago
Quality Assurance Technician
Haemonetics Corporation is a global healthcare company dedicated to improving patient outcomes. They are seeking a Quality Assurance Technician responsible for ensuring product quality through inspection, auditing, and compliance with quality systems.
BiotechnologyConsultingHealth CareMedicalMedical Device
Responsibilities
Accurately and promptly fill out required forms and paper work documenting inspection and audit functions. Assist in the management of the calibration and environmental monitoring programs
Audit Product History Records, Sterilization Records, and other documentation as required, in order to prepare product for release
Carry out specialized testing and investigation as assigned to measure and quantify specific quality issues
Evaluate and track product returned from the customer per Complaint Handling and Bowl Investigation Procedure
Perform inspection on incoming raw material per approved procedures. Assist in monitoring supplier quality trends and corrective action
Perform routine audits of the molding and assembly operation per QCP’s. Work with manufacturing to establish corrective action and assure effectiveness
Qualification
Required
H.S. Diploma Required
Strong math skills
Solid understanding of Quality Systems
Demonstrated written and verbal communication skills
Preferred
Understand all quality requirements (ex. ISO, FDA regulation, etc.) with medical device manufacturing preferred
MS Office proficiency (Excel, Outlook) preferred
Experience in the medical device industry preferred
Company
Haemonetics
Haemonetics is a provider of blood and plasma supplies and services.
H1B Sponsorship
Haemonetics has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (2)
2024 (3)
2023 (3)
2022 (2)
2021 (4)
Funding
Current Stage
Public CompanyTotal Funding
$1.75B2024-05-21Post Ipo Debt· $600M
2021-03-01Post Ipo Equity· $435M
2019-05-23Post Ipo Equity· $10M
Leadership Team
Recent News
2025-12-02
2025-11-21
2025-11-19
Company data provided by crunchbase